These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 26654211

  • 21. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N, van Nieuwenhuizen A, Clain A, Baer L, Nierenberg AA.
    Depress Anxiety; 2011 Feb; 28(2):137-44. PubMed ID: 21284066
    [Abstract] [Full Text] [Related]

  • 22. Improved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Psychol Med; 2015 Nov; 45(15):3191-204. PubMed ID: 26098793
    [Abstract] [Full Text] [Related]

  • 23. Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Behav Ther; 2019 Jul; 50(4):765-777. PubMed ID: 31208686
    [Abstract] [Full Text] [Related]

  • 24. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ, Wisniewski SR, Zisook S, Fava M, Sung SC, Haley CL, Chan HN, Gilmer WS, Warden D, Nierenberg AA, Balasubramani GK, Gaynes BN, Trivedi MH, Hollon SD.
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [Abstract] [Full Text] [Related]

  • 25. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 26. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.
    Petersen T, Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE.
    Psychol Med; 2004 Apr; 34(3):555-61. PubMed ID: 15259840
    [Abstract] [Full Text] [Related]

  • 27. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial.
    Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC.
    Arch Gen Psychiatry; 2001 Apr; 58(4):381-8. PubMed ID: 11296099
    [Abstract] [Full Text] [Related]

  • 28. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
    Gelenberg AJ, Dunner DL, Rothschild AJ, Pedersen R, Dorries KM, Ninan PT.
    J Nerv Ment Dis; 2013 Apr; 201(4):266-73. PubMed ID: 23538970
    [Abstract] [Full Text] [Related]

  • 29. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
    Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.
    J Clin Psychiatry; 2010 Sep; 71(9):1125-30. PubMed ID: 20441723
    [Abstract] [Full Text] [Related]

  • 30. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [Abstract] [Full Text] [Related]

  • 31. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U, Onder E.
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [Abstract] [Full Text] [Related]

  • 32. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Kocsis JH, Rush AJ, Markowitz JC, Borian FE, Dunner DL, Koran LM, Klein DN, Trivedi MH, Arnow B, Keitner G, Kornstein SG, Keller MB.
    Psychopharmacol Bull; 2003 Dec; 37(4):73-87. PubMed ID: 15131518
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW, Levitt AJ, Levitan RD, Michalak EE, Cheung AH, Morehouse R, Ramasubbu R, Yatham LN, Tam EM.
    JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
    [Abstract] [Full Text] [Related]

  • 34. Is sleep disturbance linked to short- and long-term outcomes following treatments for recurrent depression?
    Boland EM, Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Affect Disord; 2020 Feb 01; 262():323-332. PubMed ID: 31735410
    [Abstract] [Full Text] [Related]

  • 35. How much cognitive therapy, for which patients, will prevent depressive relapse?
    Jarrett RB, Vittengl JR, Clark LA.
    J Affect Disord; 2008 Dec 01; 111(2-3):185-92. PubMed ID: 18358541
    [Abstract] [Full Text] [Related]

  • 36. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.
    Int Clin Psychopharmacol; 2008 Sep 01; 23(5):269-75. PubMed ID: 18703936
    [Abstract] [Full Text] [Related]

  • 37. Fluoxetine in child and adolescent depression: acute and maintenance treatment.
    Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL.
    Depress Anxiety; 1998 Sep 01; 7(1):32-9. PubMed ID: 9592630
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The impact of medical comorbidity on acute treatment in major depressive disorder.
    Iosifescu DV, Nierenberg AA, Alpert JE, Smith M, Bitran S, Dording C, Fava M.
    Am J Psychiatry; 2003 Dec 01; 160(12):2122-7. PubMed ID: 14638581
    [Abstract] [Full Text] [Related]

  • 40. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.
    Cassano P, Soares CN, Cohen LS, Lyster AK, Fava M.
    Arch Womens Ment Health; 2004 Jul 01; 7(3):167-71. PubMed ID: 15241662
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.